Events
AUG 08
Q2 2019 Financial Results Conference Call
San Francisco, CA
2:00 p.m. PDT/ 5:00 p.m. EDT
San Francisco, CA
2:00 p.m. PDT/ 5:00 p.m. EDT
JUN 13
Analyst Call with Immunology Expert at 2019 EULAR
Madrid, Spain
8:00 a.m. EDT
Madrid, Spain
8:00 a.m. EDT
MAR 01
Leadership Spotlight
Dr. Jonathan Zalevsky, Chief Scientific Officer discusses bempegaldesleukin (NKTR-214)
Latest News
OUR PIPELINE
We are focused on using new chemistry approaches to make better medicines to treat cancer, chronic pain and auto-immune disease.
Cutting-edge facilities
Dynamic teams
Impactful work
OUR Culture
We are supported by a dynamic team, rich in scientific, business and medical expertise, across three locations.